Akoya, Zeiss to comarket spatial phenotyping and discovery workflow
Akoya Biosciences and Zeiss are comarketing Akoya's codetection by indexing spatial phenotyping systems with Zeiss' Axio Observer microscope. Read More
IAG to host webinar on trial imaging for accelerated drug development
Image Analysis Group (IAG) will host a webinar on Friday, May 21 at noon EST on how modern clinical trial infrastructure, including artificial intelligence and cloud platforms, can accelerate clinical drug development programs. Read More
Soteria launches to develop switchable, bispecific T-cell engagers
Soteria Biotherapeutics has closed $42 million in financing to launch as an immuno-oncology company focused on developing next-generation switchable, bispecific T-cell engagers to treat solid tumor cancers. Read More
Deerfield invests $130M in Baylor Medicine
Deerfield Management and Baylor College of Medicine have entered into a major research collaboration to advance promising therapeutics through the Blue Square Discoveries program. Read More
Charles River to acquire Vigene Biosciences for $293M
Charles River Laboratories has entered into an agreement to acquire Vigene Biosciences, a U.S-based gene therapy contract development and manufacturing organization, for $292.5 million. Read More
Interline raises $92M for drug discovery of dysfunctional proteins
Interline Therapeutics has raised $92 million to be used to expand its research platform and advance six preclinical therapeutic programs. Read More
Biogen, Envisagenics collaborate on RNA splicing
Biogen and Envisagenics have announced a new collaboration to advance RNA splicing research within central nervous system diseases. Read More
AGTC expands gene therapy manufacturing capabilities
Applied Genetic Technologies (AGTC) has initiated plans to lease a build-to-suit 21,000-sq-ft current good manufacturing practice manufacturing and quality control facility in Florida. Read More
Rare Disease Company Coalition established
A coalition of pharmaceutical and biosciences companies has launched a new organization to educate policymakers on the challenges they face bringing therapies to the market for small patient populations. Read More
NanoCellect launches new cell sorter
NanoCellect Biomedical announced it has scheduled a virtual launch for its Wolf G2 Cell Sorter. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
